Okumus, Nazli Kubra
Zeitler, Emily P.
Moustafa, Abdelmoniem http://orcid.org/0000-0001-5539-0788
Iglesias, Maximiliano
Khanna, Rahul
Rong, Yiran
Karim, Saima
Funding for this research was provided by:
Biosense Webster
Article History
Received: 11 January 2024
Accepted: 13 March 2024
First Online: 18 April 2024
Declarations
:
: This analysis of the Optum SES data was conducted under an exemption from Institutional Review Board oversight for US-based studies using de-identified healthcare records, as dictated by Title 45 Code of the Federal Regulations (45 CFR 46.101(b)(4)) (ExternalRef removed).
: Not applicable as this study is a retrospective and data was deidentified.
: Dr. Okumus, none; Dr. Moustafa, none. Dr. Zeitler reports research funding from the National Institutes of Health; research support from Sanofi and Biosense Webster; consulting for Biosense Webster, Medtronic, and Sanofi; and travel from Biosense Webster and Medtronic. Maximiliano Iglesias, Yiran Rong, and Rahul Khanna are Johnson and Johnson employees. Dr. Karim reports speakers bureau fees from Medtronic.